| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0003 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.01 |